Health ❯ Healthcare ❯ Pharmaceuticals

Weight Loss Drugs

Zepbound Wegovy GLP-1 Medications GLP-1 Agonists Mounjaro Ozempic Semaglutide GLP-1 Receptor Agonists Tirzepatide GLP-1 Drugs

Amazon Pharmacy Rolls Out Lilly’s Foundayo With Same‑Day Delivery and Clinic Kiosks

Same-day delivery with clinic kiosks signals a shift to faster, broader access.

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Hims & Hers Shares Fall After Mixed Q4 and Soft Q1 Outlook as GLP‑1 Scrutiny Intensifies

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

CagriSema Beats Semaglutide on HbA1c and Weight at 68 Weeks in Type 2 Diabetes Trial

UK Regulator Adds Severe Pancreatitis Warning to Ozempic, Wegovy and Mounjaro

Oxford BMJ Review Finds Rapid Weight Rebound After Stopping Modern Weight-Loss Drugs

FDA Approves Novo Nordisk’s Wegovy Pill, First Oral GLP-1

Lilly’s Triple-Agonist Retatrutid Delivers About 29% Weight Loss in Phase 3, with Notable Side Effects

GLP-1 Boom Hits a Crossroads as States Cut Coverage and Next‑Gen Drugs Advance

Eli Lilly Hits $1 Trillion Valuation on GLP‑1 Weight‑Loss Boom

Denmark Awards Compensation to Four Patients for Eye Damage Linked to Ozempic and Wegovy

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

Eli Lilly Lifts 2025 Guidance After Tirzepatide Fuels Blowout Quarter

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

GLP-1 Drugs Tied to Atypical PET-CT Uptake, Raising Misdiagnosis Risk